{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:42:04Z","timestamp":1793997724007,"version":"4.8.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2022-I2M-CoV19-006"],"award-info":[{"award-number":["2022-I2M-CoV19-006"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A20410"],"award-info":[{"award-number":["U20A20410"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005356","name":"Zhejiang Shuren University","doi-asserted-by":"publisher","award":["2024R057"],"award-info":[{"award-number":["2024R057"]}],"id":[{"id":"10.13039\/501100005356","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.autrev.2025.103882","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T06:46:24Z","timestamp":1752734784000},"page":"103882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Chronic inflammation in Long COVID relationship to autoimmune diseases"],"prefix":"10.1016","volume":"24","author":[{"given":"Keda","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naihui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2025.103882_bb0005","author":"World Health Organization"},{"key":"10.1016\/j.autrev.2025.103882_bb0010","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/23744235.2021.1924397","article-title":"Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments","volume":"53","author":"Yong","year":"2021","journal-title":"Infect Dis Lond Engl"},{"key":"10.1016\/j.autrev.2025.103882_bb0015","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1038\/s41467-022-30836-0","article-title":"Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records","volume":"13","author":"Thompson","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2025.103882_bb0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2478\/jtim-2020-0003","article-title":"Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management","volume":"8","author":"Liu","year":"2020","journal-title":"J Transl Intern Med"},{"key":"10.1016\/j.autrev.2025.103882_bb0025","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s00134-020-06026-1","article-title":"Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis","volume":"46","author":"Pan","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.autrev.2025.103882_bb0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2020.03.044","article-title":"Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses","volume":"526","author":"Qi","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2025.103882_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2025.103882_bb0040","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2025.103882_bb0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2025.103882_bb0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.autrev.2025.103882_bb0055","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","article-title":"Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19","volume":"21","author":"Woodruff","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2025.103882_bb0060","first-page":"56","article-title":"Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome","author":"Chen","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2025.103882_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109183","article-title":"Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection","volume":"112","author":"Vahabi","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2025.103882_bb0070","doi-asserted-by":"crossref","DOI":"10.1101\/2021.06.25.449905","article-title":"Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection","volume":"12","author":"Patterson","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103882_bb0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2500\/aap.2022.43.220018","article-title":"Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome","volume":"43","author":"Buonsenso","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.autrev.2025.103882_bb0080","unstructured":"Inflammasome activation in infected macrophages drives COVID-19 pathology | Nature n.d. https:\/\/www.nature.com\/articles\/s41586-022-04802-1 (accessed January 10, 2025)."},{"key":"10.1016\/j.autrev.2025.103882_bb0100","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2025.103882_bb0105","first-page":"327","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.autrev.2025.103882_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583373","article-title":"The Inflammasome in times of COVID-19","volume":"11","author":"de Rivero Vaccari","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103882_bb0135","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1016\/j.jaip.2023.09.014","article-title":"The Long road of Long COVID: specific considerations for the allergist\/immunologist","volume":"11","author":"Bellanti","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.autrev.2025.103882_bb0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tim.2014.09.007","article-title":"Response of host inflammasomes to viral infection","volume":"23","author":"Chen","year":"2015","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.autrev.2025.103882_bb0145","first-page":"1629","article-title":"Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.autrev.2025.103882_bb0165","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12985-022-01891-2","article-title":"Pathophysiology of post-COVID syndromes: a new perspective","volume":"19","author":"Batiha","year":"2022","journal-title":"Virol J"},{"key":"10.1016\/j.autrev.2025.103882_bb0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.5415\/apallergy.0000000000000022","article-title":"Immunological dysfunction and mast cell activation syndrome in long COVID","volume":"13","author":"Sumantri","year":"2023","journal-title":"Asia Pac Allergy"},{"issue":"24","key":"10.1016\/j.autrev.2025.103882_bb0180","first-page":"00062","article-title":"The intersection of microbiome and autoimmunity in long COVID-19: current insights and future directions","volume":"S1359-6101","author":"Hromi\u0107-Jahjefendi\u0107","year":"2024","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.autrev.2025.103882_bb0185","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jaci.2017.06.022","article-title":"Airway microbiota signals anabolic and catabolic remodeling in the transplanted lung","volume":"141","author":"Mouraux","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103882_bb0190","doi-asserted-by":"crossref","first-page":"1080043","DOI":"10.3389\/fimmu.2023.1080043","article-title":"Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID","volume":"14","author":"Ancona","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103882_bb0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainresbull.2021.04.010","article-title":"Bidirectional communication between mast cells and the gut-brain axis in neurodegenerative diseases: avenues for therapeutic intervention","volume":"172","author":"Bhuiyan","year":"2021","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.autrev.2025.103882_bb0210","doi-asserted-by":"crossref","first-page":"1465324","DOI":"10.3389\/fnut.2024.1465324","article-title":"Comparative analysis of COVID-19 responses in Japan and Africa: diet, phytochemicals, vitamin D, and gut microbiota in reducing mortality-A systematic review and meta-analysis","volume":"11","author":"Santa","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.autrev.2025.103882_bb0215","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.gastro.2021.10.013","article-title":"Prolonged impairment of short-chain fatty acid and L-isoleucine biosynthesis in gut microbiome in patients with COVID-19","volume":"162","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2025.103882_bb0220","doi-asserted-by":"crossref","first-page":"10440","DOI":"10.3390\/ijms221910440","article-title":"Molecular insights into SARS-CoV2-induced alterations of the gut\/brain Axis","volume":"22","author":"Nataf","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2025.103882_bb0225","doi-asserted-by":"crossref","first-page":"7880448","DOI":"10.1155\/2021\/7880448","article-title":"Neuropsychiatric ramifications of COVID-19: short-chain fatty acid deficiency and disturbance of microbiota-gut-brain axis signaling","volume":"2021","author":"Sajdel-Sulkowska","year":"2021","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.autrev.2025.103882_bb0230","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/s41467-021-21907-9","article-title":"Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications","volume":"12","author":"Xiao","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2025.103882_bb0240","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.3748\/wjg.v30.i37.4104","article-title":"Long COVID and gut candidiasis: what is the existing relationship?","volume":"30","author":"Bistagnino","year":"2024","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2025.103882_bb0245","doi-asserted-by":"crossref","unstructured":"Immune-mediated neurological syndromes in SARS-CoV-2-infected patients | J Neurol n.d. https:\/\/doi.org\/10.1007\/s00415-020-10108-x (accessed January 12, 2025).","DOI":"10.1007\/s00415-020-10108-x"},{"key":"10.1016\/j.autrev.2025.103882_bb0150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.autrev.2025.103882_bb0250","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/07853890.2022.2076901","article-title":"Pathophysiology and mechanism of long COVID: a comprehensive review","volume":"54","author":"Castanares-Zapatero","year":"2022","journal-title":"Ann Med"},{"key":"10.1016\/j.autrev.2025.103882_bb0260","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0042-1748170","article-title":"SARS-CoV-2-induced immunosuppression: a molecular mimicry syndrome","volume":"9","author":"Kanduc","year":"2022","journal-title":"Glob Med Genet"},{"key":"10.1016\/j.autrev.2025.103882_bb0270","unstructured":"Diverse functional autoantibodies in patients with COVID-19 | Nature n.d. https:\/\/www.nature.com\/articles\/s41586-021-03631-y (accessed April 7, 2025)."},{"key":"10.1016\/j.autrev.2025.103882_bb0275","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","article-title":"Molecular mimicry and autoimmunity","volume":"95","author":"Rojas","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2025.103882_bb0280","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.19.1.80-94.2006","article-title":"Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease","volume":"19","author":"Fujinami","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.autrev.2025.103882_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03834.x","article-title":"The role of infections in autoimmune disease","volume":"155","author":"Ercolini","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2025.103882_bb0295","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/088282401753266756","article-title":"Virus-induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease","volume":"14","author":"Olson","year":"2001","journal-title":"Viral Immunol"},{"key":"10.1016\/j.autrev.2025.103882_bb0300","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12863-022-01040-2","article-title":"SARS-CoV-2 and human retroelements: a case for molecular mimicry?","volume":"23","author":"Koch","year":"2022","journal-title":"BMC Genomic Data"},{"key":"10.1016\/j.autrev.2025.103882_bb0315","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3390\/v14071415","article-title":"Potential autoimmunity resulting from molecular mimicry between SARS-CoV-2 spike and human proteins","volume":"14","author":"Nunez-Castilla","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.autrev.2025.103882_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103882_bb0330","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fimmu.2018.00187","article-title":"The possible effect of B-cell epitopes of Epstein-Barr virus early antigen, membrane antigen, latent membrane Protein-1, and -2A on systemic lupus erythematosus","volume":"9","author":"Tu","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103882_bb0335","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.bor.0000240355.37927.94","article-title":"Epstein-Barr virus and systemic lupus erythematosus","volume":"18","author":"James","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2025.103882_bb0340","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nm1167","article-title":"Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry","volume":"11","author":"McClain","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2025.103882_bb0345","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/08916930500484849","article-title":"Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus","volume":"39","author":"Poole","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2025.103882_bb0350","article-title":"Epstein-Barr functional mimicry: pathogenicity of oncogenic latent membrane Protein-1 in systemic lupus erythematosus and autoimmunity","volume":"11","author":"Munroe","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103882_bb0355","first-page":"45","article-title":"Epstein-Barr virus infection induces lupus autoimmunity","volume":"64","author":"Harley","year":"2006","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.autrev.2025.103882_bb0360","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1515\/mr-2024-0030","article-title":"Review of organ damage from COVID and Long COVID: a disease with a spectrum of pathology","volume":"5","author":"Ewing","year":"2025","journal-title":"Med Rev"},{"key":"10.1016\/j.autrev.2025.103882_bb0365","first-page":"12","article-title":"Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms","author":"Proal","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.autrev.2025.103882_bb0405","article-title":"NETosis and neutrophil extracellular traps in COVID-19: immunothrombosis and beyond","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103882_bb0435","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1515\/mr-2024-0013","article-title":"Understanding autoimmune response after SARS-CoV-2 infection and the pathogenesis\/mechanisms of long COVID","volume":"4","author":"Guo","year":"2024","journal-title":"Med Rev"},{"key":"10.1016\/j.autrev.2025.103882_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109183","article-title":"Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection","volume":"112","author":"Vahabi","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2025.103882_bb0565","doi-asserted-by":"crossref","first-page":"97","DOI":"10.52586\/S555","article-title":"Review article on COVID-19 and Guillain-Barr\u00e9 syndrome","volume":"13","author":"Patnaik","year":"2021","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1016\/j.autrev.2025.103882_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102695","article-title":"SARS-CoV-2, the autoimmune virus","volume":"19","author":"Halpert","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103882_bb0790","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/1756-185X.13909","article-title":"Understanding immunopathological fallout of human coronavirus infections including COVID-19: will they cross the path of rheumatologists?","volume":"23","author":"Kabeerdoss","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103882_bb0695","doi-asserted-by":"crossref","unstructured":"Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies | Clin Rheumatol n.d. https:\/\/doi.org\/10.1007\/s10067-021-05580-3 (accessed January 12, 2025).","DOI":"10.1007\/s10067-021-05580-3"},{"key":"10.1016\/j.autrev.2025.103882_bb0455","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s10067-020-05310-1","article-title":"Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology","volume":"39","author":"Mantovani Cardoso","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2025.103882_bb0460","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejr.2021.08.013","article-title":"Systemic lupus erythematosus after coronavirus disease-2019 (COVID-19) infection: case-based review","volume":"44","author":"Assar","year":"2022","journal-title":"Egypt Rheumatol"},{"key":"10.1016\/j.autrev.2025.103882_bb0465","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cytogfr.2009.02.004","article-title":"Interferon-gamma: a historical perspective","volume":"20","author":"Billiau","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.autrev.2025.103882_bb0470","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10067-023-06758-7","article-title":"Neutralizing anti-IFN-\u03b3 IgG was increased in patients with systemic lupus erythematosus and associated with susceptibility to infection","volume":"43","author":"Chen","year":"2024","journal-title":"Clin Rheumatol"},{"issue":"176","key":"10.1016\/j.autrev.2025.103882_bb0475","first-page":"5995","article-title":"In vivo and in vitro regulation of type I IFN synthesis by synergistic effects of CD40 and type II IFN","volume":"2006","author":"Greene","year":"1950","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.autrev.2025.103882_bb0480","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1471-4906(01)01955-X","article-title":"An etiopathogenic role for the type I IFN system in SLE","volume":"22","author":"R\u00f6nnblom","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2025.103882_bb0485","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1136\/annrheumdis-2015-208140","article-title":"Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification","volume":"75","author":"Munroe","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103882_bb0490","article-title":"IFN-\u03b3, should not be ignored in SLE","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103882_bb0495","first-page":"326","article-title":"Interferon regulatory factors in human lupus pathogenesis","volume":"157","author":"Salloum","year":"2011","journal-title":"Transl Res J Lab Clin Med"},{"key":"10.1016\/j.autrev.2025.103882_bb0525","doi-asserted-by":"crossref","first-page":"1227505","DOI":"10.3389\/fneur.2023.1227505","article-title":"Acute motor-sensory axonal polyneuropathy variant of Guillain-Barr\u00e9 syndrome with a thalamic lesion and COVID-19: a case report and discussion on mechanism","volume":"14","author":"Geng","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2025.103882_bb0530","article-title":"Guillain-Barr\u00e9 syndrome associated with COVID-19: A systematic review","volume":"28","author":"Pimentel","year":"2023","journal-title":"Brain Behav Immun - Health"},{"key":"10.1016\/j.autrev.2025.103882_bb0535","article-title":"Guillain-Barr\u00e9 syndrome in an elderly patient as a complication of COVID-19 infection","volume":"13","author":"Miyajan","year":"2021","journal-title":"Cureus"},{"issue":"67","key":"10.1016\/j.autrev.2025.103882_bb0540","first-page":"318","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: a scoping review","volume":"2021","author":"de Medeiros","year":"1992","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.autrev.2025.103882_bb0545","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.937989","article-title":"A remarkable case of acute motor-sensory axonal polyneuropathy (AMSAN) variant of Guillain Barr\u00e9 syndrome, in a diabetic patient infected with COVID-19: a case report and review of the literature","volume":"13","author":"Ali","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2025.103882_bb0550","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/jns.12382","article-title":"Guillain-Barr\u00e9 syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature","volume":"25","author":"Scheidl","year":"2020","journal-title":"J Peripher Nerv Syst JPNS"},{"key":"10.1016\/j.autrev.2025.103882_bb0555","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s12192-020-01145-6","article-title":"SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism","volume":"25","author":"Lucchese","year":"2020","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.autrev.2025.103882_bb0570","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/mus.27024","article-title":"COVID-19-associated Guillain-Barr\u00e9 syndrome: the early pandemic experience","volume":"62","author":"Caress","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2025.103882_bb0575","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/fampra\/cmac029","article-title":"The development of inflammatory arthritis following SARS-CoV-2 infection: a systematic review of the literature","volume":"39","author":"Chaudhry","year":"2022","journal-title":"Fam Pract"},{"key":"10.1016\/j.autrev.2025.103882_bb0615","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/ard.54.3.216","article-title":"Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and Proteus mirabilis in rheumatoid arthritis","volume":"54","author":"Wilson","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103882_bb0620","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1473-3099(23)00685-0","article-title":"A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial","volume":"24","author":"Lau","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.autrev.2025.103882_bb0655","article-title":"Sequential multi-omics analysis identifies clinical phenotypes and predictive biomarkers for long COVID","volume":"4","author":"Wang","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.autrev.2025.103882_bb0660","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12985-024-02408-9","article-title":"Long non-coding RNAs in biomarking COVID-19: a machine learning-based approach","volume":"21","author":"Heydari","year":"2024","journal-title":"Virol J"},{"key":"10.1016\/j.autrev.2025.103882_bb0665","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.700782","article-title":"Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning","volume":"12","author":"Patterson","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103882_bb0670","doi-asserted-by":"crossref","first-page":"19743","DOI":"10.1038\/s41598-024-70929-y","article-title":"Long COVID diagnostic with differentiation from chronic Lyme disease using machine learning and cytokine hubs","volume":"14","author":"Patterson","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2025.103882_bb0675","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1056\/NEJMra1909094","article-title":"Reframing immune-mediated inflammatory diseases through signature cytokine hubs","volume":"385","author":"Schett","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2025.103882_bb0715","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/BCJ20220016","article-title":"A central role for amyloid fibrin microclots in long COVID\/PASC: origins and therapeutic implications","volume":"479","author":"Kell","year":"2022","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2025.103882_bb0720","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/s-0043-1774796","article-title":"A perspective on how fibrinaloid microclots and platelet pathology may be applied in clinical investigations","volume":"50","author":"Pretorius","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.autrev.2025.103882_bb0725","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1055\/s-0043-1774795","article-title":"What role does microthrombosis play in Long COVID?","volume":"50","author":"Iba","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.autrev.2025.103882_bb0680","doi-asserted-by":"crossref","unstructured":"Lupus anticoagulant and mortality in patients hospitalized for COVID-19 | J Thromb Thrombolysis n.d. https:\/\/doi.org\/10.1007\/s11239-020-02335-w (accessed January 12, 2025).","DOI":"10.1007\/s11239-020-02335-w"},{"key":"10.1016\/j.autrev.2025.103882_bb0730","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1080\/14712598.2023.2296569","article-title":"Intravenous immunoglobulin as a potential treatment for long COVID","volume":"23","author":"McCarthy","year":"2023","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.autrev.2025.103882_bb0735","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13101","article-title":"Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease","volume":"94","author":"Danieli","year":"2021","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2025.103882_bb0755","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1080\/14656566.2023.2262387","article-title":"Paxlovid as a potential treatment for long COVID","volume":"24","author":"McCarthy","year":"2023","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.autrev.2025.103882_bb0760","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.70075","article-title":"Analysis of Nirmatrelvir entry into pulmonary lining fluid in patients with COVID-19: a unique perspective to explore and understand the target plasma concentration of 292ng\/mL in antiviral activity","volume":"12","author":"Zhang","year":"2024","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.autrev.2025.103882_bb0820","first-page":"154","article-title":"Intestinal fibrosis in Crohn\u2019s disease: towards new therapeutic options?","volume":"80","author":"Vieujean","year":"2025","journal-title":"Rev Med Liege"},{"key":"10.1016\/j.autrev.2025.103882_bb0835","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/acsmedchemlett.9b00219","article-title":"Targeting IRAK4 for degradation with PROTACs","volume":"10","author":"Nunes","year":"2019","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.autrev.2025.103882_bb0645","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13063-021-05180-1","article-title":"A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial","volume":"22","author":"Akova","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.autrev.2025.103882_bb0650","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.21037\/apm-20-1365","article-title":"A narrative review of relationship between gut microbiota and neuropsychiatric disorders: mechanisms and clinical application of probiotics and prebiotics","volume":"10","author":"Yang","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.autrev.2025.103882_bb0685","article-title":"Long COVID: the nature of thrombotic sequelae determines the necessity of early anticoagulation","volume":"12","author":"Wang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.autrev.2025.103882_bb0690","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/bloodadvances.2021005945","article-title":"American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis","volume":"6","author":"Cuker","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.autrev.2025.103882_bb0700","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/jama.2021.4152","volume":"325","author":"INSPIRATION Investigators","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2025.103882_bb0705","article-title":"Anticoagulation in COVID-19: not strong for too long?","volume":"40","author":"Tacquard","year":"2021","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.autrev.2025.103882_bb0740","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1111\/ene.15508","article-title":"Antibody response after COVID-19 vaccination in intravenous immunoglobulin-treated immune neuropathies","volume":"29","author":"Sva\u010dina","year":"2022","journal-title":"Eur J Neurol"},{"issue":"58","key":"10.1016\/j.autrev.2025.103882_bb0770","first-page":"539","article-title":"Optimizing the use of Paxlovid in clinical practice","volume":"2022","author":"McCarthy","year":"1998","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.autrev.2025.103882_bb0780","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/jth.14867","article-title":"Lupus anticoagulant is frequent in patients with Covid-19","volume":"18","author":"Harzallah","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2025.103882_bb0815","doi-asserted-by":"crossref","DOI":"10.1038\/d41573-025-00061-7","article-title":"Trends in the drug target landscape for autoimmune diseases","author":"Fauconnier","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.autrev.2025.103882_bb0825","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/gutjnl-2024-332504","article-title":"Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD","volume":"74","author":"Bamias","year":"2025","journal-title":"Gut"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225001429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225001429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:14:52Z","timestamp":1772759692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225001429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":107,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1568997225001429"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103882","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic inflammation in Long COVID relationship to autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103882","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103882"}}